Back

Cardiotoxicity associated with cancer therapy: incidence and predictors in patients with breast cancer

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 2 - Chronic heart failure (CHF) Cardiotoxicity of drugs ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Filipa Cordeiro

Hospital Senhora da Oliveira - Guimaraes, Creixomil (Portugal)

30 More presentations in this session

Presentation thumbnail
Endogenous selenoprotein P mediates pressure overload-induced cardiac hypertrophy.
Associate Professor S. Usui (Kanazawa, JP)
Abstract Slides
Presentation thumbnail
Regulation of essential myosin light chain phosphorylation in dilated cardiomyopathy
Mrs M. Mueller (Heidelberg, DE)
Abstract
Presentation thumbnail
Assessing right ventricular morphological changes and dysfunction on long-term lymphoma survivors received anthracycline by three-dimensional speckle tracking echocardiography
Doctor L. Cheng (Shanghai, CN)
Abstract
Presentation thumbnail
Chemotherapy and biological therapy induced cardio-toxicity-data from a tertiary center
Doctor A. Younis (Ramat Gan, IL)
Abstract Slides
Presentation thumbnail
Cardiac toxicity evaluated with magnetic resonance in mexican oncologic population
Doctor A. Jordan (Mexico City, MX)
Abstract Slides

Access the full session

Session thumbnail
Poster session 2 - Chronic heart failure (CHF)

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources